Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Mar 2, 2026
Reporting period
Not applicable
Filed with the SEC
Mar 4, 2026
CFOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001628280-26-014440
Filed / recorded
Mar 4, 2026, 4:47 PM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
BECTON DICKINSON & CO
Issuer CIK
10795
Ticker
BDX
Reporting person
Vitor Roque
Relationship
Officer
Officer title
Interim CFO
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Mar 2, 2026
Transaction code
A
Shares / units
931
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
6,510
Ownership form
Direct
Amendment
No
Footnotes from the filing
Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.
Around the same time
Congress tradeSits on House Ways and Means, Health
Congress tradeSits on House Ways and Means, Health
